Ar­se­nal­Bio lands $70M cash deal with can­cer gi­ant Genen­tech to de­vel­op cell ther­a­py

San Fran­cis­co-based Ar­se­nal­Bio’s de­sign­er T cells pro­gram is at­tract­ing the at­ten­tion of some big play­ers.

Af­ter clos­ing a deal and grab­bing $70 mil­lion in cash …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER